CHINA / National

    China cracks 167,000 cases of illegal medical production in H1
    (Xinhua)
    Updated: 2006-08-15 21:31

    BEIJING -- China uncovered 167,000 cases of illegal production and trade in medicines and medical equipment in the first half of this year, according to the State Food and Drug Administration (SFDA).

    A total of 260 million yuan (US$32.5 million) was involved in the cases and more than 200 underground drug production sites were shut down.

    Fraudulent pharmaceutical company registration procedures were also detected and punished. The SFDA inspected 14 companies and investigated 131 kinds of drugs between January and June, said head of SFDA Shao Mingli.

    Meanwhile, the administration monitored 270,000 illegal advertisements in the public domain of drugs, medical equipment and health foods and reported them to the industrial and commercial authorities.

    The administration also punished 20 companies for illegal production during the first half of the year, said Shao.

    It is planning to launch a one-year national campaign to regulate the drug market, which will target malpractice in drug research, production, distribution and application as well as slack supervision.

    The decision was made after the administration came to the conclusion that the cause of a problematic antibiotic injection case, which left six dead, was improper sterilization during its production.

    The "Xinfu" drug, manufactured in June and July by Anhui Huayuan Worldbest Biology Pharmacy Co., wasn't sterilized properly, with both the sterilization temperature and time below the state-required safety level.

    The administration has so far recalled more than 1.2 million bottles of the drug, 173,007 are being returned to the factory and more than 403,170 bottles have been sealed up in other areas.

    Two months earlier, a fake injection produced by the Qiqihar No. 2 Pharmaceutical Co.,Ltd., a privately-owned business in northeast China's Heilongjiang Province, caused 11 deaths in China.

    Both of the companies involved in the two accidents are qualified pharmaceutical companies and their products were sold through legal channels.

    The incidents prove that more efforts need to be devoted to checking raw materials, production facilities, workers' qualifications and managers' awareness of responsibilities in the drug industry, said Shao.

     
     

    久久精品中文字幕久久| 69ZXX少妇内射无码| yy111111少妇无码影院| 最近完整中文字幕2019电影| 99无码熟妇丰满人妻啪啪| 中文字幕无码久久久| 亚洲精品成人无码中文毛片不卡| 精品无码一区二区三区爱欲九九| 中文字幕久久精品| 欧美日韩国产中文字幕| 久久亚洲精品无码观看不卡| 亚洲不卡中文字幕无码| 日本欧美亚洲中文| 中文字幕AV中文字无码亚| 国产精品无码不卡一区二区三区| 一本色道久久HEZYO无码| 天堂在线观看中文字幕| 视频二区中文字幕| 日本aⅴ精品中文字幕| 亚洲av无码成人精品区在线播放| 日韩精品真人荷官无码| 永久免费av无码入口国语片| 中文字幕一区二区三区乱码| √天堂中文官网在线| 中文字幕乱码人妻无码久久| 少妇人妻综合久久中文字幕| 久久久久亚洲?V成人无码| 精品久久久久久无码人妻蜜桃 | 久久久久无码国产精品不卡| 精品无码AV一区二区三区不卡 | 人妻丰满熟妇AV无码片| 亚洲精品无码久久一线| 亚洲精品无码永久在线观看你懂的| 久久无码专区国产精品发布| 少妇性饥渴无码A区免费| 中文字幕在线无码一区二区三区 | 无码国内精品人妻少妇蜜桃视频| 中文字幕无码乱人伦| 亚洲成A人片在线观看无码不卡| 亚洲AV无码久久精品色欲| 无码精品国产VA在线观看DVD|